Brian Park, PharmD

Drug Information Specialist https://www.medicalbag.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

News

Kevzara Approved for Polymyalgia Rheumatica

Brian Park, PharmD

March 17, 2023

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper.

News

Generic Version of Pylera an H. Pylori Treatment, Now Available

Brian Park, PharmD

March 17, 2023

Each capsule contains 140mg of bismuth subcitrate potassium, 125mg of metronidazole, and 125mg of tetracycline hydrochloride.

News

FDA: Early Structural Valve Deterioration Possible With Abbott Trifecta Valves

Brian Park, PharmD

March 16, 2023

The Trifecta and Trifecta GT valves are heart valve replacement devices designed to treat diseased, damaged, or malfunctioning native or prosthetic aortic heart valves.

News

Intravitreal Methotrexate Under Review for Primary Vitreoretinal Lymphoma

Brian Park, PharmD

March 16, 2023

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ADX-2191 (methotrexate injection) for the treatment of primary vitreoretinal lymphoma, a rare, aggressive retinal cancer. ADX-2191 is a preservative-free, intravitreal formulation of methotrexate designed to be vitreous-compatible. The application is supported by safety data from the phase 3…

News

Omecamtiv Mecarbil Denied Approval for Heart Failure

Brian Park, PharmD

March 16, 2023

The FDA is requiring the Company to conduct an additional clinical trial evaluating omecamtiv mecarbil for HFrEF.

News

M-M-R II, Varivax, ProQuad Vaccines Approved for Intramuscular Administration

Brian Park, PharmD

March 16, 2023

M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.

News

FDA Approves Autoinjector Presentation of Pegfilgrastim Biosimilar Udenyca

Brian Park, PharmD

March 16, 2023

The new autoinjector is designed with push-on-skin activation to be used in both in-office and at-home settings of care.

News

Berdazimer Gel Under Review for Molluscum Contagiosum

Brian Park, PharmD

March 16, 2023

The application is supported by data from the pivotal phase 3 B-SIMPLE4 study which included 891 patients 6 months of age and older with molluscum contagiosum.

News

Dupilumab Under Review for Chronic Spontaneous Urticaria

Brian Park, PharmD

March 16, 2023

The sBLA is supported by data from Studies A and B of phase 3 LIBERTY-CUPID trial which included patients with CSU who were inadequately controlled on standard-of-care H1 antihistamines.

News

Syfovre Approved for Geographic Atrophy Secondary to AMD

Brian Park, PharmD

March 16, 2023

The approval was based on data from the phase 3 DERBY and OAKS studies.

Next post in News